KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Other Operating Expenses (2017 - 2025)

Cardlytics (CDLX) has disclosed Other Operating Expenses for 8 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses changed N/A year-over-year to $5.1 million, compared with a TTM value of $4.8 million through Dec 2025, changed N/A, and an annual FY2025 reading of $4.8 million, changed N/A over the prior year.
  • Other Operating Expenses was $5.1 million for Q3 2025 at Cardlytics, up from -$200000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $430.3 million in Q4 2022 and bottomed at -$444000.0 in Q1 2022.
  • Average Other Operating Expenses over 4 years is $81.3 million, with a median of $61.6 million recorded in 2021.
  • The sharpest move saw Other Operating Expenses plummeted 100.89% in 2022, then skyrocketed 6286.94% in 2023.
  • Year by year, Other Operating Expenses stood at $76.1 million in 2021, then surged by 465.49% to $430.3 million in 2022, then tumbled by 61.5% to $165.7 million in 2023, then tumbled by 96.9% to $5.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for CDLX at $5.1 million in Q3 2025, -$200000.0 in Q2 2025, and -$100000.0 in Q1 2025.